{"classes":[{"categories":[{"measurements":[{"comment":"Median was not reached due to insufficient number of participants with events","groupId":"OG000","lowerLimit":"NA","upperLimit":"NA","value":"NA"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"34"}],"units":"Participants"}],"description":"Time to recurrence or death","dispersionType":"95% Confidence Interval","groups":[{"description":"Capecitabine 1000mg/day for one year\n\ncapecitabine\n\nadjuvant therapy","id":"OG000","title":"Capecitabine"}],"paramType":"MEDIAN","populationDescription":"All enrolled participants","reportingStatus":"POSTED","timeFrame":"Within 3 years of end of study.","title":"Recurrence-free Survival","type":"SECONDARY","unitOfMeasure":"months"}